The role of inflammation in head and neck cancer

Advances in Experimental Medicine and Biology

Volumn 816, Issue , 2014, Pages 107-127

  Bonomi, Marcelo ^a   Patsias, Alexis ^b   Posner, Marshall ^b   Sikora, Andrew ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APRICOXIB; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 32; MACROPHAGE MIGRATION INHIBITION FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN KINASE B; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA; CELL PROTEIN; CHEMOKINE; CYTOKINE; DESMOYOKIN; GROWTH FACTOR; INTERLEUKIN 6; PROSTAGLANDIN; PROSTAGLANDIN E2; TELOMERASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; UVOMORULIN;

AHNAK GENE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CHEMOPROPHYLAXIS; DRUG EFFICACY; EPITHELIAL MESENCHYMAL TRANSITION; HEAD AND NECK CANCER; HOMEOSTASIS; HUMAN; HUMAN PAPILLOMA VIRUS RELATED OROPHARYNGEAL CARCINOMA; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFLAMMATION; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE REPAIR; TUMOR GENE; TUMOR INVASION; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; GENE OVEREXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; TUMOR VASCULARIZATION;

EID: 84959212377     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-348-837-8_5     Document Type: Article

References (112)

1. Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M et al (2001) Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 20(43):6196-6204
2. Allen C, Duffy S, Teknos T, Islam M, Chen Z, Albert PS et al (2007) Nuclear factor-kappaBrelated serum factors as longitudinal biomarkers of response and survival in advanced orophary ngeal carcinoma. Clin Cancer Res Off J Am Assoc Cancer Res 13(11):3182-3190
3. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. New Engl J Med 363(1):24-35
4. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539-545
5. Bekes E M, Schweighofer B, Kupriyanova TA, Zajac E, Ardi VC, Quigley JP et al (2011) Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell in travasation. Am J Pathol 179(3):1455-1470
6. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR et al (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammator y and atherogenic cell recruitment. Nat Med 13(5):587-596
7. Bian Y, Hall B, Sun ZJ, Molinolo A, Chen W, Gutkind JS et al (2012) Loss of TGF-beta signaling an d PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene 31(28):3322-3332
8. Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M et al (2008) Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res 68(6):1809-1819
9. Bigbee WL, Grandis JR, Siegfried JM (2007) Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients. Clin Cancer Res Off J Am Assoc Cancer Res 13(11):3107-3108
10. Bucala R, Donnelly SC (2007) Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26(3):281-285
11. Buchanan FG Wang D Bargiacchi F D uBois RN 2003 Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor J Biol Chem 278 37 35451-35457
12. Bunt SK, Sinha P, Clements VK, Le ips J, Ostrand-Rosenberg S (2006) Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol (Baltimore, Md 1950) 176(1):284-290
13. Bunt SK, Yang L, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S (2007) Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 67(20):10019-10026
14. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW et al (1999) Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res Off J Am Assoc Cancer Res 5(6):1369-1379
15. Chen T, Yan W, Wells RG, Rimm DL, McNiff J, Leffell D et al (2001) Novel inactivating mutations of transforming growth factor-beta type I receptor gene in he ad-and-neck cancer metastases. Int J Cancer 93(5):653-661 (Journal international du cancer
16. Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR et al (2004) Simultaneously targeting epidermal growth fa ctor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Clin Cancer Res Off J Am Assoc Cancer Res 10(17):5930-5939
17. Chung CH, Gillison ML (2009) Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res Off J Am Assoc Cancer Res 15(22):6758-6762
18. Chung JH, Rho JK, Xu X, Lee J S, Yoon HI, Lee CT et al (2011) Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs. Lung Cancer (Amst Neth) 73(2):176-182
19. Cooper JS, Pajak TF, Fo rastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. New Eng J Med 350(19):1937-1944 Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860-867
20. Curado MP, Hashibe M (2009) Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21(3):194-200
21. Dannenberg AJ, Subbaramaiah K (2003) Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 4(6):431-436
22. De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200(4):429-447
23. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425(6958):577-584
24. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87(6):2095-2147
25. Dohadwala M, Yang SC, Luo J, Sharma S, Batra RK, Huang M et al (2006) Cyclooxyge nase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res 66(10):5338-5345
26. D'Souza G, Kreimer AR, Viscidi R, P awlita M, Fakhry C, Koch WM et al (2007) Casecontrol study of human papillomavirus and oropharyngeal cancer. New Engl J Med 356(19):1944-1956
27. Dumitru CA, Gholaman H, Trellakis S, Bruder ek K, Dominas N, Gu X et al (2011) Tumorderived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer 129(4):859-869 (Journal international du cancer
28. Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S (2012a) Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunoth (CII) 61(8):1155-1167
29. Dumitru CA, Fechner MK, Hoffmann TK, Lang S, Brandau S (2012b) A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer. J Leukoc Biol 91(4):591-598
30. Dumitru CA, Bankfalvi A, Gu X, Zeidler R, Brandau S, Lang S (2013) AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma. PLoS One 8(2):e56420
31. Elwood PC, Gallagher AM, Duthie GG, Mur LA, Morgan G (2009) Aspirin, salicylates, and cancer. Lancet 373(9671):1301-1309
32. Engle SJ Hoying JB Boivin GP Ormsby I Gartsi de PS Doetschman T 1999 Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesisi Cancer Res 59 14 3379-3386
33. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. New Engl J Med 349(22):2091-2098
34. Gasche JA, Hoffmann J, Boland CR, Goel A (2011) Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer 129(5):1053-1063
35. Gentil BJ, Delphin C, Mbele GO, Deloulme JC, Ferro M, Garin J et al (2001) The giant protein AHNAK is a specific target for the calcium-and zinc-binding S100B protein: potential implications for Ca2+ homeostasis re gulation by S100B. J Biol Chem 276(26):23253-23261
36. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100(6):407-420
37. Gregory AD, Houghton AM (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71(7):2411-2416
38. Grieb G, Merk M, Bernhagen J, Bucala R (2010) Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 23(4):257-264
39. Guenin S, Mouallif M, Hubert P, Jacobs N, Krusy N, Duray A et al (2013) Interleukin-32 expression is associated with a poorer prognosis in head and neck squamous cell carcinoma. Mol Carcinog
40. Gurova KV, Hill JE, Guo C, Prok volit A, Burdelya LG, Samoylova E et al (2005) Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci USA 102(48):17448-17453
41. Haase H, Podzuweit T, Lutsch G, Hohaus A, Kostka S, Lindschau C et al (1999) Signaling from beta-adrenoceptor to L-type calcium channel: identification of a novel cardiac protein kinase A target possessing similarities to AHNAK. FASEB 13(15):2161-2172
42. Haddad Y, Choi W, McConkey DJ (2009) Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epide rmal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines. Clin Cancer Res 15(2):532-542
43. Haque MF, Meghji S, Khitab U, Harris M (2000) Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med 29(3):123-128
44. Hashimoto T, Gamou S, Shimizu N, Kitajima Y, Nishikawa T (1995) Regulation of translocation of the desm oyokin/AHNAK protein to the plasma membrane in keratinocytes by protein kinase C. Exp Cell Res 217(2):258-266
45. Heinhuis B, Koenders MI, van Riel PL, van de Loo FA, Dinarello CA, Netea MG et al (2011) Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade. Ann Rheum Dis 70(4):660-667
46. Henderson YC, Wang E, Clayman GL (1998) Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas. Laryngoscope 108(10):1553-1556
47. Hirano T, Ishihara K, Hibi M (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19(21):2548-2556
48. Hohaus S, Ma ssini G, Giachelia M, Vannata B, Bozzoli V, Cuccaro A et al (2010) Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol 28(15):2538-2543
49. Holla VR, Backlund MG, Yang P, Newman RA, DuBois RN (2008) Regulation of prostaglandin transporters in colorectal neoplasia. Cancer Prev Res (Philadelphia, Pa) 1(2):93-99
50. Ichikawa A, Sugimoto Y, Negishi M (1996) Molecular aspects of the structures and functions of the prostaglandin E receptors. J Lipid Mediat Cell Signal 14(1-3):83-87
51. Jablonska J, Les chner S, Westphal K, Lienenklaus S, Weiss S (2010) Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest 120(4):1151-1164
52. Jaeckel EC , Raja S, Tan J, Das SK, Dey SK, Girod DA et al (2001) Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cel l carcinoma. Arch Otolaryngol Head Neck Surg 127(10):1253-1259
53. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277-300
54. Jeng J H, Wang YJ, Chiang BL, Lee PH, Chan CP, Ho YS et al (2003) Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNFalpha production of oral epithelial cells by areca nut ext ract and arecoline. Carcinogenesis 24(8):1301-1315
55. John MAS, Dohadwala M, Luo J, Wang G, Lee G, Shih H et al (2009) Proinflammatory mediators upregulate snail in head and neck squamous c ell carcinoma. Clin Cancer Res 15(19):6018-6027
56. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE et al (2001) Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103(18):2260-2265
57. Kang YH, Park MY, Yoon DY, Han SR, Lee CI, Ji NY et al (2012) Dysregulation of overexpressed IL-32alpha in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-kappaB and Bcl-2. Cancer Lett 318(2):226-233
58. Kao J, Genden EM, Chen CT, Rivera M, Tong CC, Misiukiewicz K et al (2011) Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer. Cancer 117(14):3173-3181
59. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA (2005) Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22(1):131-142
60. Kim YY, Lee EJ, Kim YK, Kim SM, Park JY, Myoung H et al (2010) Anti-cancer effects of celecoxib in head and neck carcinoma. Mol Cells 29(2):185-194
61. Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE et al (2011) A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol 195 (3):417-433
62. Kross KW, Heimdal JH, Aarstad HJ (2010) Mononuclear phagocytes in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 267(3):335-344
63. Kuang DM, Zhao Q, Wu Y, Peng C, Wang J, Xu Z et al (2011) Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol 54(5):948-955
64. Lee JI, Soria JC, Hassan KA, El-Naggar AK, Tang X, Liu DD et al (2001) Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg 127(12):1441-1445
65. Lee TL, Yang XP, Yan B, Friedman J, Duggal P, Bagain L et al (2007) A novel nuclear factorkappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 statu s. Clin Cancer Res 13(19):5680-5691
66. Lee TL, Yeh J, Friedman J, Yan B, Yang X, Yeh NT et al (2008) A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BA X/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. Int J Cancer 122(9):1987-1998
67. Lee SH, Lee SJ, Jung YS, Xu Y, Kang HS, Ha NC et al (2009) Blocki ng of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function. Neoplasia (NY) 11(1):22-31 (6p following
68. Lee J, Taneja V, Vassallo R (2012) Cigarette smoking and inflammation: cellular and molecular mechanisms. J Dent Res 91(2):142-149
69. Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117(5):1175-1183
70. Lu SL, Herrington H, Reh D, Weber S, Bornstein S, Wang D et al (2006) Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev 20(10):1331-1342
71. Lyford-Pike S, Peng S, Young GD, Taube JM, Westra WH, Akpeng B et al (2013) Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck s quamous cell carcinoma. Cancer Res 73(6):1733-1741
72. Massague J (2008) TGFbeta in cancer. Cell 134(2):215-230
73. McCaul JA, Gordon KE, Clark LJ, Parkinson EK (2002) Telomerase inhibition and the future management of head-and-neck cancer. Lancet Oncol 3(5):280-288
74. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS (2009) Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 45(4-5):324-334
75. Moustakas A, Heldin CH (2009) The regulation of TGFbeta signal transduction. Dev (Cambridge, Engl) 136(22):3699-3714
76. Nibali L Fedele S D'Aiuto F Donos N 2012 Interleukin-6 in oral diseases: a review Oral Dis 18 3 236-243
77. Nishimoto N (2010) Interleukin-6 as a therapeutic target in candidate inflammatory diseases. Clin Pharmacol Ther 87(4):483-487
78. Nozawa H, Chiu C, Hanahan D (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103(33):12493-12498
79. Papa dimitrakopoulou VA, William WN Jr, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG et al (2008) Pilot randomized phase II study of celecoxib in oral premalignant lesions. Clin Cancer Res 14(7):2095-2101
80. Pasche B, Knobloch TJ, Bian Y, Liu J, Phukan S, Rosman D et al (2005) Somatic acquisition and signaling of TGFBR16A in cancer. JAMA 294(13):1634-1646
81. Pedrero JM, Car racedo DG, Pinto CM, Zapatero AH, Rodrigo JP, Nieto CS et al (2005) Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma. Int J Cancer 114(2):242-248
82. Perez-Ordonez B, Beauchemin M, Jordan RC (2006) Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 59(5):445-453
83. Piek E, Roberts AB (2001) Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis. Adv Cancer Res 83:1-54
84. Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA et al (2007) TP53 mutations and survival in squamous-cell carcinoma of the head and neck. New Engl J Med 357(25):2552-2561
85. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V et al (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. New Engl J Med 357(17):1705-1715
86. Reckamp K, Gitlitz B, Chen LC, Patel R, Milne G, Syto M et al (2011) Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in ad vanced nonsmall cell lung cancer. Cancer 117(4):809-818
87. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W et al (1996) High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56(16):3630-3633
88. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular diseas e in apparently healthy men. New Engl J Med 336(14):973-979
89. Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR (2010) Pseudopodial actin dynamics control epithelial-mesenchymal t ransition in metastatic cancer cells. Cancer Res 70(9):3780-3790
90. Shao X, Tandon R, Samara G, Kanki H, Yano H, Close LG et al (1998) Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma. Int J Cancer 77(5):684-688
91. Shiboski CH, Schmidt BL, Jordan RC (2005) Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 103(9):1843-1849
92. Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S et al (2007) Epithelial overexpression of interleukin-32 alpha in inflammatory bowel disease. Clin Exp Immunol 149(3):480-486
93. Shtivelman E, Cohen FE, Bishop JM (1992) A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. Proc Natl Acad Sci USA 89(12):5472-5476
94. St John MA, Wang G, Luo J, Dohadwala M, Hu D, Lin Y et al (2012) Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies. Br J Cancer 107(4):707-712
95. Sundelin K, Roberg K, Grenman R, Hakansson L (2005) Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro. Acta Otolaryngol 125(7):765-773
96. Sussman J Stokoe D Ossina N Shtivelman E 2001 Protein kinase B phosphorylates AHNAK and regulates its subcellular localization J Cell Biol 154 5 1019-1030
97. Tanaka M, Jin G, Yamazaki Y, Takahara T, Takuwa M, Nakamura T (2008) Identificati on of candidate cooperative genes of the Apc mutation in transformation of the colon epithelial cell by retroviral insertional mutagenesis. Cancer Sci 99(5):979-985
98. Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR et al (2003) TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 112(7):1116-1124
99. Tergaonkar V, Perkins ND (2007) p53 and NF-kappaB crosstalk: IKKalpha tips the balance. Mol Cell 26(2):158-159
100. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890
101. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. Ne w Engl J Med 366(26):2443-2454
102. Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, Bankfalvi A et al (2011) Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 129(9):2183-2193
103. Van Waes C (2007) Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res Off J Am Assoc Cancer Res 13(4):1076-1082
104. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. New Engl J Med 357(17):1695-1704
105. Wang F, Arun P, Friedman J, Chen Z, Van Waes C (2009) Current and potential inflammation targeted therapies in head and neck cancer. Curr Opin Pharmacol 9(4):389-395
106. Wilson JC, Anderson LA, Murray LJ, Hughes CM (2011) Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review. Cancer Causes Control (CCC) 22(5):803-810
107. Wilson JC, Murray LJ, Hughes CM, Black A, Anderson LA (2013) Non-st eroidal antiinflammatory drug and aspirin use and the risk of head and neck cancer. Br J Cancer 108(5):1178-1181
108. Worden B, Yang XP, Lee TL, Bagain L, Yeh NT, Cohen JG et al (2005) Hepat ocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. Cancer Res 65(16):7071-7080
109. Xie W, Bharathy S, Kim D, Haffty BG, Rimm DL, Reiss M (2003) Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis. Oncol Res 14(2):61-73
110. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF et al (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101(2):311-320
111. Zhan g YE (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19(1):128-139
112. Zhang K, Zhaos J, Liu X, Yan B, Chen D, Gao Y et al (2011) Activation of NF-B upregulates Snail and cons equent repression of E-cadherin in cholangiocarcinoma cell invasion. Hepatogastroenterology 58(105):1-7